Migraine incidence, comorbidity and health resource utilization in the UK

Cephalalgia

Volumn 28, Issue 1, 2008, Pages 57-64

  Becker, C ^a   Brobert, G P ^b   Almqvist, P M ^b   Johansson, S ^c,d   Jick, S S ^e   Meier, C R ^a,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ASTRAZENECA R AND D   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Comorbidity; Epidemiology; GPRD; Health resource utilization; Migraine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCLIZINE; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; CODEINE; CYCLIZINE; DEXTROPROPOXYPHENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOMPERIDONE; ERGOT ALKALOID; ESTROGEN; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROCHLORPERAZINE; PROMETHAZINE; TRIFLUOPERAZINE; TRIPTAN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; ASTHMA; BIPOLAR DISORDER; CANCER; CASE CONTROL STUDY; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEPRESSION; DISEASE SEVERITY; ENTERITIS; EPILEPSY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH CARE UTILIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PSYCHOSIS; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEALTH RESOURCES; HUMANS; INCIDENCE; INFANT; MALE; MENTAL DISORDERS; MIDDLE AGED; MIGRAINE DISORDERS; PRIMARY HEALTH CARE; SEX FACTORS;

EID: 36749069349     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01469.x     Document Type: Article

References (39)

1. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol 2006 13 : 333 45.
2. Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lanteri-Minet M et al. Prevalence and clinical characteristics of migraine in France. Neurology 2002 59 : 232 7.
3. Dahlof C, Linde M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 2001 21 : 664 71.
4. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003 23 : 519 27.
5. Lampl C, Buzath A, Baumhackl U, Klingler D. One-year prevalence of migraine in Austria: a nation-wide survey. Cephalalgia 2003 23 : 280 6.
6. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41 : 646 57.
7. Takeshima T, Ishizaki K, Fukuhara Y, Ijiri T, Kusumi M, Wakutani Y et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 2004 44 : 8 19.
8. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991 134 : 1111 20.
9. Breslau N, Davis GC, Schultz LR, Peterson EL. Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache 1994 34 : 387 93.
10. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2005 161 : 1066 73.
11. Stang PE, Yanagihara PA, Swanson JW, Beard CM, O'Fallon WM, Guess HA 3rd et al. Incidence of migraine headache: a population-based study in Olmsted County, Minnesota. Neurology 1992 42 : 1657 62.
12. Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ 2006 332 : 25 9.
13. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 87 : 543 52.
14. Zwart JA, Dyb G, Hagen K, Odegard KJ, Dahl AA, Bovim G et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003 10 : 147 52.
15. Markush RE, Karp HR, Heyman A, O'Fallon WM. Epidemiologic study of migraine symptoms in young women. Neurology 1975 25 : 430 5.
16. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology 1994 44 : 2105 10.
17. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 2003 23 : 441 50.
18. Dueland AN, Leira R, Burke TA, Hillyer EV, Bolge S. The impact of migraine on work, family, and leisure among young women - a multinational study. Curr Med Res Opin 2004 20 : 1595 604.
19. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992 46 : 443 6.
20. Pop PH, Gierveld CM, Karis HA, Tiedink HG. Epidemiological aspects of headache in a workplace setting and the impact on the economic loss. Eur J Neurol 2002 9 : 171 4.
21. Goldberg LD. The cost of migraine and its treatment. Am J Manag Care 2005 11 (2 Suppl. S62 7.
22. Walley T, Mantgani A. The UK general practice research database. Lancet 1997 350 : 1097 9.
23. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR et al. Validity of the general practice research database. Pharmacotherapy 2003 23 : 686 9.
24. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004 24 (Suppl. 1 1 160.
25. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 (Suppl. 7 1 96.
26. Mavromichalis I, Anagnostopoulos D, Metaxas N, Papanastassiou E. Prevalence of migraine in schoolchildren and some clinical comparisons between migraine with and without aura. Headache 1999 39 : 728 36.
27. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994 309 : 765 9.
28. Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 1992 34 : 1095 101.
29. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994 44 (6 Suppl. 4 S17 23.
30. Nachit-Ouinekh F, Chrysostome V, Henry P, Sourgen C, Dartigues JF, El Hasnaoui A. Variability of reported headache symptoms and diagnosis of migraine at 12 months. Cephalalgia 2005 25 : 117 23.
31. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998 38 : 87 96.
32. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003 60 : 1308 12.
33. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990 47 : 849 53.
34. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003 289 : 65 9.
35. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001 322 : 19 22.
36. Markley HG. Verapamil and migraine prophylaxis: mechanisms and efficacy. Am J Med 1991 90 : 48S 53S.
37. Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE et al. Postmenopausal hormone therapy and migraine headache. J Womens Health (Larchmt) 2003 12 : 1027 36.
38. Ryan RE. A controlled study of the effect of oral contraceptives on migraine. Headache 1978 17 : 250 2.
39. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003 43 : 19 26.